6-氨基-1-甲基-3,4-二氢喹啉-2-酮 | 233775-30-9

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 6-氨基-1-甲基-3,4-二氢喹啉-2-酮
• 英文名称: 6-amino-1-methyl-3,4-dihydroquinolin-2(1H)-one
• 英文别名: 6-amino-1-methyl-3,4-dihydroquinolin-2-one
• CAS: 233775-30-9
• 化学式: C₁₀H₁₂N₂O
• mdl: MFCD11987121
• 分子量: 176.218
• InChiKey: ULWJTPAOSJSHFG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933790090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  ——	1-methyl-6-nitro-3,4-dihydroquinolin-2(1H)-one	233775-29-6	C10H10N2O3	206.201
  3,4-二氢-2(1H)-喹啉酮	3,4-dihydro-2(1H)-quinolone	553-03-7	C9H9NO	147.177
  6-硝基-3,4-二氢-2(1H)-喹啉酮	6-nitro-3,4-dihydro-1H-quinolin-2-one	22246-16-8	C9H8N2O3	192.174

• 下游产品

  中文名称	英文名称	CAS号	化学式	分子量
  ——	(1-methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-carbamic acid benzyl ester	233775-31-0	C18H18N2O3	310.353
  ——	4-cyclohexyl-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)benzene-1-sulfonamide	——	C22H26N2O3S	398.526

反应信息

• 作为反应物：
  描述：

  6-氨基-1-甲基-3,4-二氢喹啉-2-酮 在 叔丁基过氧化氢 作用下， 以 N,N-二甲基甲酰胺 、 乙腈 、 叔丁醇 为溶剂， 反应 28.0h， 生成 3-hydroxy-1-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-2-oxopyrrolidine-3-carboxylic acid 3-chloro-5-fluorobenzyl amide
  参考文献：
  名称：

  Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer

  摘要：

  The recently disclosed next generation of reversible, selective, and potent MetAP-2 inhibitors introduced a cyclic tartronic diamide scaffold. However, the lead compound la suffered from enterohepatic circulation, preventing further development. Nevertheless, la served as a starting point for further optimization. Maintaining potent antiproliferation activity, while improving other compound properties, enabled the generation of an attractive array of new MetAP-2 inhibitors. The most promising derivatives were identified by a multiparameter analysis of the compound properties. Essential for the efficient selection of candidates with in vivo activity was the identification of molecules with a long residence time on the target protein, high permeability, and low efflux ratio not only in Caco-2 but also in the MDR-MDCK cell line. Orally bioavailable, potent, and reversible MetAP-2 inhibitors impede the growth of primary endothelial cells and demonstrated antitumoral activity in mouse models. This assessment led to the nomination of the clinical development compound M8891, which is currently in phase I clinical testing in oncology patients.

  DOI：

  10.1021/acs.jmedchem.9b01070
• 作为产物：
  描述：

  3,4-二氢-2(1H)-喹啉酮 在 硫酸 、 硝酸 、 铁粉 、 potassium carbonate 、 氯化铵 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 30.5h， 生成 6-氨基-1-甲基-3,4-二氢喹啉-2-酮
  参考文献：
  名称：

  Tetrahydroquinolinyl phosphinamidates and phosphonamidates enhancing tolerance towards drought stress in crops via interaction with ABA receptor proteins

  摘要：

  New phosphorous-containing lead structures against drought stress in crops interacting with RCAR/(PYR/PYL) receptor proteins were identified starting from in-depth SAR studies of related sulfonamide lead structures and protein docking studies. A converging 6-step synthesis via phosphinic chlorides and phosphono chloridates as key intermediates afforded envisaged tetrahydroquinolinyl phosphinamidates and phosphonamidates. Whilst tetrahydroquinolinyl phosphonamidates 13a,b exhibited low to moderate target affinities, the corresponding tetrahydroquinolinyl phosphinamidates 12a,b revealed confirmed strong affinities for RCAR/ (PYR/PYL) receptor proteins in Arabidopsis thaliana on the same level as essential plant hormone abscisic acid (ABA) combined with promising efficacy against drought stress in vivo (broad-acre crops wheat and canola).

  DOI：

  10.1016/j.bmc.2020.115725

文献信息

• N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
  申请人：——

  公开号：US20040147760A1

  公开（公告）日：2004-07-29

  The present invention provides antibacterial agents having the formulae I, II, and III described herein.

  本发明提供了具有以下式I、II和III的抗菌剂。
• [EN] OXAZOLIDINONE ANTIBACTERIAL AGENTS<br/>[FR] AGENTS ANTIBACTERIENS OXAZOLIDINONE
  申请人：PHARMACIA & UPJOHN CO LLC

  公开号：WO2005082897A1

  公开（公告）日：2005-09-09

  The present invention relates to novel amidoxime and amidine oxazolidinones of formula I , wherein R2, Y1, Y 2, Y3, X, W, G and U are as defined herein in the specification. The compounds of the present invention have potent activities against gram-positive bacteria.

  本发明涉及公式I的新型酰胺肟和酰胺噁唑啉，其中R2、Y1、Y2、Y3、X、W、G和U如本说明书中所定义。本发明的化合物对革兰氏阳性细菌具有强大的活性。
• [EN] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS<br/>[FR] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES ET LEURS DERIVES ET UTILISATION DE CES COMPOSES COMME ANTIBACTERIENS
  申请人：UPJOHN CO

  公开号：WO2003072553A1

  公开（公告）日：2003-09-04

  Compounds of formula B-C-A-CO-NH-R1, wherein A is structure i, ii or iii: formulae (I), (II), (III). C is optionally substituted aryl or heteroaryl, and B is a specified cyclic moiety, or C and B together are a heterobicyclic moiety, are useful as antibacterial agents.

  公式为B-C-A-CO-NH-R1的化合物，其中A是结构i、ii或iii：公式(I)、(II)、(III)。C是可选择取代的芳基或杂环芳基，而B是特定的环状基团，或者C和B一起是一个杂双环基团，可用作抗菌剂。
• [EN] COMPOUNDS ACTIVE TOWARDS BROMODOMAINS<br/>[FR] COMPOSÉS ACTIFS ENVERS DES BROMODOMAINES
  申请人：NUEVOLUTION AS

  公开号：WO2016016316A1

  公开（公告）日：2016-02-04

  Disclosed are compounds towards bromodomains, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

  揭示了针对溴结构域的化合物，含有这些化合物的药物组合物以及这些化合物在治疗中的用途。
• [EN] BIFUNCTIONAL MOLECULES CONTAINING AN E3 UBIQUITINE LIGASE BINDING MOIETY LINKED TO A BCL6 TARGETING MOIETY<br/>[FR] MOLÉCULES BIFONCTIONNELLES CONTENANT UNE FRACTION DE LIAISON À L'UBIQUITINE LIGASE E3 LIÉE À UNE FRACTION CIBLANT BCL6
  申请人：ARVINAS OPERATIONS INC

  公开号：WO2021077010A1

  公开（公告）日：2021-04-22

  Bifunctional compounds, which find utility as modulators of B-cell lymphoma 6 protein (BCL6; target protein), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand that binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本发明描述了双功能化合物，其作为B细胞淋巴瘤6蛋白（BCL6；靶蛋白）的调节剂。特别是，本发明中的双功能化合物一端含有与相应的E3泛素连接酶结合的Von Hippel-Lindau、cereblon、凋亡蛋白抑制剂或小鼠双分钟同源蛋白2的配体，另一端含有与靶蛋白结合的部分，使得靶蛋白被置于泛素连接酶附近，以促进靶蛋白的降解（和抑制）。本发明中的双功能化合物展示了与靶蛋白降解/抑制相关的广泛药理活性。可以通过本发明中的化合物和组合物治疗或预防由靶蛋白聚集或积累引起的疾病或失调。